Common Contracts

SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT

Exclusive License Agreement • February 14th, 2022 • Neumora Therapeutics, Inc. • Biological products, (no disgnostic substances)

• Contract Type
  Exclusive License Agreement
• Filed
  February 14th, 2022
• Company
  Neumora Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)

This Second Amendment (“Amendment”) is entered into effective as of April 9, 2019 and is made to the EXCLUSIVE LICENSE AGREEMENT dated November 23, 2015 as amended on November 13, 2017 (the “Agreement”) by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI“), and BLACKTHORN THERAPEUTICS, NC., a Delaware corporation (“Licensee”).